POINT Biopharma Global Profit Margin

As of the most recent data (September 2023), PNT shows a profit margin of 39.62%. That is above the Healthcare sector average of 15.58%. Scroll down for historical charts and peer comparison views.

The Healthcare sector average profit margin is about 15.58%. POINT Biopharma Global is at 39.62%, which is higher that average. That is roughly 154.2% above the sector mean. Use the comparison chart on this page to see how PNT stacks up against individual peers as well.

Check the historical chart to see whether PNT's profit margin is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare POINT Biopharma Global with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has POINT Biopharma Global's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 39.62%) with ownership activity and broader fundamentals.

The Healthcare average profit margin is about 15.58%, while PNT is at 39.62%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.